Tethered yohimbine analogs as selective human α 2Cadrenergic receptor ligands

Journal of Pharmacology and Experimental Therapeutics

Volumn 319, Issue 2, 2006, Pages 739-748

  Bavadekar, Supriya A ^a   Ma, Guoyi ^b   Mustafa, Suni M ^c   Moore, Bob M ^c   Miller, Duane D ^c   Feller, Dennis R ^a,b  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR; ADRENERGIC RECEPTOR BLOCKING AGENT; AMINE; CARBENE; CYCLIC AMP; LIGAND; LUCIFERASE; RADIOLIGAND; YOHIMBINE DERIVATIVE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CHO CELL; CONTROLLED STUDY; DRUG INHIBITION; DRUG RECEPTOR BINDING; DRUG STRUCTURE; HUMAN; HUMAN CELL; NONHUMAN; PHARMACOPHORE; PRIORITY JOURNAL;

ANIMALS; CHO CELLS; CRICETINAE; CYCLIC AMP; DIMERIZATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LIGANDS; MEDETOMIDINE; RADIOLIGAND ASSAY; RECEPTORS, ADRENERGIC, ALPHA-2; STRUCTURE-ACTIVITY RELATIONSHIP; YOHIMBINE;

EID: 33751159212     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.105981     Document Type: Article

References (19)

1. Angers S, Salahpour A, and Bouvier M (2002) Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. Annu Rev Pharmacol Toxicol 42:409-435.
2. 2-adrenergic receptors: comparison of pharmacologically defined subtypes with subtypes identified by molecular cloning. Mol Pharmacol 42:1-5.
3. Bylund DB, Bond RA, Clarke DE, Eikenburg DC, Hieble JP, Langer SZ, Lefkowitz RJ, Minneman KP, Molinoff PB, Ruffolo RR, et al. (1998) Adrenoceptors, in The IUPHAR Compendium of Receptor Characterization and Classification, 1st ed, pp 58-74, IUPHAR Media Company, Burlington Press, Cambridge, UK.
4. 50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
5. 2C-adrenergic receptors enable cold-induced vasoconstriction in cutaneous arteries. Am J Physiol 278:H1075-H1083.
6. s. J Biol Chem 267:15795-15801.
7. 2C-Adrenergic receptors mediate spinal analgesia and adrenergic-opioid synergy. J Pharmacol Exp Ther 300:282-290.
8. 2-adrenergic receptors regulate sympathetic transmission. Nature (Lond) 402:181-184.
9. 2C-AR subtype. J Pharmacol Exp Ther 303:979-984.
10. Lipinski CA, Lombardo F, Dominy BW, and Feeney PJ (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 23:3-25.
11. 2C-adrenergic receptors. Bioorg Med Chem Lett 15:2758-2760.
12. 2- adrenergic receptor subtypes to cyclic AMP-dependent reporter gene expression in transiently transfected JEG-3 cells. Mol Pharmacol 44:802-809.
13. 2-adrenoceptor knockout mice. Eur J Endocrinol 149:343-350.
14. Portoghese P (2001) 2000 Alfred Burger Award Address in Medicinal Chemistry: From models to molecules: opioid receptor dimers, bivalent ligands, and selective opioid receptor probes. J Med Chem 44:2259-2269.
15. 2C-adrenoceptor as a neuropsychiatric drug target: studies in transgenic mouse models. Life Sci 68:2277-2285.
16. Vansal SS and Feller DR (1999) An efficient cyclic AMP assay for the functional evaluation of β-adrenergic receptor ligands. J Recept Signal Transduct Res 19:853-863.
17. 2-adrenoceptor agonist. Eur J Pharmacol 150:9-14.
18. 2- Adrenergic Receptor Ligands. Doctoral dissertation, Graduate Studies Council, University of Tennessee Health Science Center, Memphis, TN.
19. 2b-adrenergic receptors. Bioorg Med Chem Lett 10:627-630.